How Long Does Greater Trochanteric Pain Syndrome Last?

Greater trochanteric pain syndrome (GTPS) lasts anywhere from a few months to many years, depending on the person and how it is managed. A primary care study found that roughly 60 percent of patients had recovered by the one-year mark, but at least 36 percent still had lateral hip pain after a year, and 29 percent still had it after five years.¹ An 11-year follow-up found that nearly half of people originally diagnosed with GTPS still had the condition over a decade later.² That wide range can be frustrating when you just want a number, and the honest answer is that the condition behaves differently from person to person based on what is driving it, what else is going on in your body, and which treatments you pursue.

What Is Actually Happening in the Hip

The name “greater trochanteric pain syndrome” is an umbrella term for pain at the bony bump on the outer side of your hip. For decades this was written off as trochanteric bursitis, the assumption being that a small fluid-filled sac near the hip was inflamed. Imaging research has largely retired that idea. MRI and ultrasound studies show that the pain is more commonly caused by problems in the gluteus medius and gluteus minimus tendons, the muscles that stabilize your pelvis when you stand on one leg, walk, or climb stairs.³ Bursitis may be present alongside tendon damage, but it is usually a secondary finding rather than the main event. This distinction matters for prognosis because an irritated bursa can settle down relatively quickly with rest and anti-inflammatory medication, while a degenerating or partially torn tendon follows a slower, less predictable recovery curve.

Why Duration Varies So Much

Several factors influence whether your case resolves in weeks or drags on for years. The most consistent finding across studies is that women are far more likely to develop GTPS and to have it persist. One large epidemiological study found that women had roughly three times the odds of developing it compared to men, even after adjusting for other risk factors.⁴ The reasons are partly structural: women tend to have wider pelvises, which changes the angle of force on the gluteal tendons. A systematic review with meta-analysis confirmed that people with GTPS tend to have wider trochanters, weaker hip abductor muscles, and altered gait patterns like shorter steps and slower walking speed.⁵

Coexisting osteoarthritis in the hip or knee is one of the strongest predictors of a longer course. Patients with osteoarthritis in the lower limbs had nearly five times the risk of still having symptoms a year later compared to those without it.¹ This makes sense biomechanically: if your knee or hip joint is stiff or painful, you compensate by shifting your posture and gait, which loads the gluteal tendons differently and keeps the cycle going. Low back pain, iliotibial band tightness, and loss of pelvic control during daily movement have all been linked to the development and persistence of GTPS.⁶

The Short-Term Picture

In the first few months, many people see meaningful improvement with relatively simple measures: avoiding positions that compress the tendon (like lying on the affected side or sitting cross-legged), managing load on the hip, and using over-the-counter pain relief. A randomized trial in primary care found that by three months, about a third of patients in a “usual care” group had recovered without any injection or specialized treatment.⁷ So if your pain is recent and mild, there is a decent chance it resolves on its own within a few months.

Corticosteroid injections can speed things up in the short run. In that same trial, about 55 percent of the injection group had recovered by three months, compared to 34 percent with usual care alone. But by the 12-month mark, both groups had converged: roughly 60 percent of each group had recovered, and there was no meaningful difference in pain levels.⁷ A meta-analysis of randomized trials reinforced this pattern, finding that corticosteroid injections may outperform a wait-and-see approach in the first few months but do not offer a lasting advantage over exercise or other active treatments.⁸ This is the central tension of GTPS management: injections can buy you short-term relief, but they are not a cure for the underlying tendon problem.

When It Becomes Chronic

The data on longer-term outcomes are sobering for anyone hoping the condition always burns itself out. At one year, about four in ten patients in primary care still had pain.¹ The 11-year follow-up study paints an even more striking picture: 45 percent of people who originally had GTPS still met the criteria for it over a decade later, compared to just 5 percent of age- and sex-matched controls.² That study also found that 35 percent of the GTPS group had developed clinical hip osteoarthritis, while none of the control participants had. Whether GTPS predisposes you to hip osteoarthritis or both conditions share common risk factors remains an open question, but the overlap is worth knowing about if you have had lateral hip pain for a long time.

Despite these numbers, the long-term follow-up data did contain some reassurance. Even though pain and disability scores were worse in the GTPS group, their overall quality of life and basic functional measures were similar to those of people who had never had the condition.² In other words, having persistent GTPS does not necessarily mean you end up significantly disabled. Many people find ways to manage it, even if the pain never fully disappears.

Why Imaging Can Be Misleading

If you have had an MRI for lateral hip pain, the results may have confused more than clarified. One study looking at MRI findings alongside clinical symptoms found that 88 percent of hips without any trochanteric pain still showed abnormalities around the greater trochanter on imaging.⁹ The one finding that did correlate meaningfully with symptoms was gluteal tendinopathy, which appeared in 88 percent of symptomatic hips versus 50 percent of pain-free hips. But partial-thickness tendon tears and fluid signals around the trochanter did not reliably distinguish painful hips from painless ones. The practical takeaway: if your MRI shows a “tear” or “bursitis,” that does not necessarily mean those findings are causing your pain, and it certainly does not dictate how long your recovery will take.

That said, when tendon tears are severe and confirmed as the pain source, especially in people who have failed conservative treatment, the picture changes. A small prospective study of patients with refractory GTPS who went to surgery found confirmed gluteus medius tears in all cases. Those tears were driving the pain, and surgical repair resulted in complete pain relief in seven of eight patients over a follow-up period averaging about two years.¹⁰ The distinction between “incidental MRI finding” and “structural tear causing your symptoms” is one that your clinician should help you parse.

Treatments That Affect How Long It Lasts

Exercise-Based Rehabilitation

Targeted strengthening of the hip abductors is the most consistently recommended treatment and the one with the best long-term track record. A trial comparing home-based exercise, corticosteroid injection, and shockwave therapy found that at 15 months, the home training group had an 80 percent success rate, which was significantly better than the injection group’s 48 percent.¹¹ Exercise takes longer to produce results. At the four-month mark in that trial, exercise lagged behind both shockwave therapy and injections. The payoff comes later. The rehabilitation period typically spans four months to a year before you see the full benefit.¹² That time investment discourages some people, but the evidence consistently shows that exercise is more durable than injections.

Shockwave Therapy

Extracorporeal shockwave therapy has gained ground as an option for people who plateau with exercise alone. In the trial mentioned above, radial shockwave therapy had a 68 percent success rate at four months and 74 percent at 15 months, outperforming corticosteroid injections at both time points.¹¹ A separate randomized trial of focused shockwave therapy showed that average pain scores dropped from about 6 out of 10 at baseline to 2 out of 10 at two months in the treatment group, compared to a drop to only about 5 in the control group.¹³ However, another trial comparing shockwave therapy with exercise found that both groups improved over time with no statistically significant difference between them, suggesting that shockwave may work best as an add-on rather than a replacement for strengthening.¹⁴

Platelet-Rich Plasma

Platelet-rich plasma (PRP) injections have emerged as an alternative for people with persistent tendon-related GTPS. A systematic review of PRP for this condition found that across multiple trials, PRP consistently outperformed corticosteroid injections over the medium and long term. One randomized trial reported that PRP benefits lasted up to two years, while corticosteroid relief peaked at six weeks and faded by six months.¹⁵ A broader scoping review confirmed the same pattern: PRP showed more promise for long-term pain management and function, though short-term results sometimes favored corticosteroids.¹⁶ At three months, 60 percent of PRP recipients in a randomized controlled trial had meaningful pain reduction versus a third in a control needling group.¹⁷ PRP is not cheap and is often not covered by insurance, but the growing evidence base makes it a reasonable option to discuss with your provider if standard treatments have not worked after several months.

When Surgery Enters the Conversation

Surgery for GTPS is reserved for people who have failed prolonged conservative treatment, typically at least six to twelve months of structured rehabilitation, injections, and activity modification. The most common procedures involve repairing the torn gluteus medius or minimus tendons, either through an open incision or endoscopically. One study of endoscopic gluteus medius repair found that 14 of 15 patients showed improvement across all outcome measures at an average follow-up of about two and a half years, with satisfaction rated as good to excellent in nearly all cases.¹⁸ Average pain scores dropped from about 7 out of 10 before surgery to about 2 out of 10 at two years after.¹⁹ Recovery after surgery is not quick. You are generally looking at several months of supervised rehabilitation before returning to full activity, and close adherence to the rehabilitation protocol is considered essential.¹²

The Nervous System and Psychological Health

One reason GTPS can become so stubborn is that the problem is not always limited to the tendon itself. Research has found evidence of central sensitization in people with persistent GTPS. In simple terms, this means the nervous system becomes more reactive to pain signals over time, amplifying discomfort even if the original tissue injury is healing. A case-control study found that about 44 percent of GTPS participants showed signs of central sensitization, including lower pain thresholds not just at the hip but at remote body sites as well.²⁰ This helps explain why some people’s pain feels out of proportion to what imaging shows.

Psychological health is intertwined with all of this. A cross-sectional study found that people with persistent GTPS had significantly higher levels of depression and anxiety than pain-free controls, along with lower quality of life and less physical activity. Depression, hip abductor strength, and stair-climbing ability together explained about a quarter of the variation in pain and disability.²¹ That finding does not mean the pain is “in your head.” It means that chronic pain and mood exist in a feedback loop. Treating one without addressing the other often leaves people stuck. If your GTPS has lasted more than a few months and you are noticing changes in your mood, sleep, or general well-being, bringing that up with your provider is as relevant as discussing your hip.

The Menopause Connection

GTPS is disproportionately common in women between their forties and sixties, and menopause appears to play a role beyond just demographics. A randomized trial tested whether menopausal hormone therapy, exercise, or a combination of both improved outcomes in postmenopausal women with GTPS. The groups receiving hormone therapy showed significantly better scores on a validated tendon-pain outcome measure at both 12 weeks and 52 weeks, particularly in women with a body mass index under 25.²² Declining estrogen is known to affect tendon health broadly, and this trial suggests that the hormonal shift of menopause may be one driver of the condition’s persistence in this age group. Hormone therapy is obviously not a casual recommendation and involves its own risk-benefit calculus, but the finding underscores that GTPS in postmenopausal women is not purely a mechanical problem. If you are in this demographic and struggling with treatment-resistant lateral hip pain, the hormonal dimension is worth discussing with your doctor.

1
PubMed Central. Prognosis of trochanteric pain in primary care
2
PubMed Central. The natural history of greater trochanteric pain syndrome: an 11-year follow-up study
3
PubMed. MRI and US of gluteal tendinopathy in greater trochanteric pain syndrome
4
PubMed Central. Greater Trochanteric Pain Syndrome: Epidemiology and Associated Factors
5
PubMed. Physical findings differ between individuals with greater trochanteric pain syndrome and healthy controls: A systematic review with meta-analysis
6
PubMed Central. Classification Based Treatment of Greater Trochanteric Pain Syndrome (GTPS) with Integration of the Movement System
7
PubMed Central. Corticosteroid injections for greater trochanteric pain syndrome: a randomized controlled trial in primary care
8
PubMed Central. The effect of corticosteroid injection in the treatment of greater trochanter pain syndrome: a systematic review and meta-analysis of randomized controlled trials
9
Skeletal Radiology. Correlation of MRI findings with clinical findings of trochanteric pain syndrome
10
PubMed. Prospective study of refractory greater trochanter pain syndrome. MRI findings of gluteal tendon tears seen at surgery. Clinical and MRI results of tendon repair
11
PubMed. Home training, local corticosteroid injection, or radial shock wave therapy for greater trochanter pain syndrome
12
PubMed Central. Rehabilitation After Gluteus Medius and Minimus Treatment
13
Journal of Bone and Joint Surgery. Focused Shockwave Treatment for Greater Trochanteric Pain Syndrome
14
PubMed Central. Shock Waves and Therapeutic Exercise in Greater Trochanteric Pain Syndrome: A Prospective Randomized Clinical Trial with Cross-Over
15
PubMed Central. Greater Trochanteric Pain Syndrome and the Efficacy of Platelet-Rich Plasma Injections: A Systematic Review
16
PubMed Central. The Efficacy and Safety of Orthobiologic Treatments for Greater Trochanteric Pain Syndrome: A Comprehensive Scoping Review
17
PubMed Central. Ultrasound-Guided Subfascial Platelet-Rich Plasma Injections Versus Enthesis Needling for Greater Trochanteric Pain Syndrome: A Randomized Controlled Trial
18
PubMed. Outcomes of endoscopic gluteus medius repair with minimum 2-year follow-up
19
Journal of Bone and Joint Surgery. Outcomes of Endoscopic Gluteus Medius Repair: Study of Thirty-four Patients with Minimum Two-Year Follow-up
20
Musculoskeletal Science & Practice. Features of central sensitisation in greater trochanteric pain syndrome: A case-control study
21
PubMed. Individuals with Persistent Greater Trochanteric Pain Syndrome Exhibit Impaired Pain Modulation, as well as Poorer Physical and Psychological Health, Compared with Pain-Free Individuals: A Cross-Sectional Study
22
PubMed Central. Does Menopausal Hormone Therapy, Exercise, or Both Improve Pain and Function in Postmenopausal Women With Greater Trochanteric Pain Syndrome? A 2 × 2 Factorial Randomized Clinical Trial